FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2151036341> ?p ?o ?g. }

• W2151036341 abstract "Urothelial carcinoma (UC) is a common cancer affecting many patients in the United States. Nephroureterectomy remains the gold standard for the treatment of high grade upper tract disease or low grade tumors that are not amenable to endoscopic management. Recent reports have shown a decrease in UC recurrence in patients who underwent nephroureterectomy and who had Mitomycin C (MMC) instilled into the bladder at the time of catheter removal. At our institution instillation of intravesical MMC at the time of nephroureterectomy has been common for more than 10 years. Given the recent data, we sought to formally describe our experience with and evaluate the safety of intravesical instillation of cytotoxic chemotherapy at the time of nephroureterectomy.We retrospectively reviewed 51 patients who underwent intraoperative intravesical instillation of cytotoxic chemotherapy (MMC (n = 48) or adriamycin (n = 3)) at the time of nephroureterectomy (2000-2012). The procedure was performed in a similar fashion by 8 different surgeons from the same institution, with drainage of the bladder prior to management of the bladder cuff. Patient characteristics and perioperative data including complications out to 90 days after surgery were collected. Perioperative complications for all patients were graded using the modified Clavien-Dindo classification.Twenty-four men and 27 women underwent intraoperative intravesical instillation of cytotoxic chemotherapy at the time of nephroureterectomy. Median age at the time of operation was 74 years (range 48-88). Median dwell time was 60 min. Twenty three patients had a total of 45 perioperative complications. The majority (36/45) were Clavien grades I and II. No patients experienced any intraoperative or postoperative complications attributable to MMC or Adriamycin instillation.Intraoperative intravesical instillation of cytotoxic chemotherapy at the time of nephroureterectomy is safe and feasible. Multicenter trials to study the efficacy of early cytotoxic chemotherapy administration to prevent recurrence of bladder urothelial carcinoma following nephroureterectomy are warranted." @default.
• W2151036341 created "2016-06-24" @default.
• W2151036341 creator A5000879830 @default.
• W2151036341 creator A5003263712 @default.
• W2151036341 creator A5004328117 @default.
• W2151036341 creator A5022280624 @default.
• W2151036341 creator A5030889638 @default.
• W2151036341 creator A5053326285 @default.
• W2151036341 creator A5057307016 @default.
• W2151036341 creator A5085293654 @default.
• W2151036341 creator A5087220330 @default.
• W2151036341 date "2015-05-28" @default.
• W2151036341 modified "2023-09-30" @default.
• W2151036341 title "Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy" @default.
• W2151036341 cites W1532961821 @default.
• W2151036341 cites W1799620269 @default.
• W2151036341 cites W1925929547 @default.
• W2151036341 cites W1981266090 @default.
• W2151036341 cites W1981401641 @default.
• W2151036341 cites W2009476629 @default.
• W2151036341 cites W2013882707 @default.
• W2151036341 cites W2021565712 @default.
• W2151036341 cites W2035725351 @default.
• W2151036341 cites W2038111129 @default.
• W2151036341 cites W2043211343 @default.
• W2151036341 cites W2049969106 @default.
• W2151036341 cites W2055414030 @default.
• W2151036341 cites W2082409153 @default.
• W2151036341 cites W2094652255 @default.
• W2151036341 cites W2096998881 @default.
• W2151036341 cites W2110599321 @default.
• W2151036341 cites W2113364705 @default.
• W2151036341 cites W2123614023 @default.
• W2151036341 cites W2143756573 @default.
• W2151036341 cites W2159142738 @default.
• W2151036341 cites W2161817637 @default.
• W2151036341 cites W2165543889 @default.
• W2151036341 cites W2336312348 @default.
• W2151036341 cites W2410979595 @default.
• W2151036341 cites W40576421 @default.
• W2151036341 cites W4237486803 @default.
• W2151036341 doi "https://doi.org/10.1186/s12894-015-0039-0" @default.
• W2151036341 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4446833" @default.
• W2151036341 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26018765" @default.
• W2151036341 hasPublicationYear "2015" @default.
• W2151036341 type Work @default.
• W2151036341 sameAs 2151036341 @default.
• W2151036341 citedByCount "16" @default.
• W2151036341 countsByYear W21510363412017 @default.
• W2151036341 countsByYear W21510363412018 @default.
• W2151036341 countsByYear W21510363412019 @default.
• W2151036341 countsByYear W21510363412020 @default.
• W2151036341 countsByYear W21510363412021 @default.
• W2151036341 countsByYear W21510363412022 @default.
• W2151036341 countsByYear W21510363412023 @default.
• W2151036341 crossrefType "journal-article" @default.
• W2151036341 hasAuthorship W2151036341A5000879830 @default.
• W2151036341 hasAuthorship W2151036341A5003263712 @default.
• W2151036341 hasAuthorship W2151036341A5004328117 @default.
• W2151036341 hasAuthorship W2151036341A5022280624 @default.
• W2151036341 hasAuthorship W2151036341A5030889638 @default.
• W2151036341 hasAuthorship W2151036341A5053326285 @default.
• W2151036341 hasAuthorship W2151036341A5057307016 @default.
• W2151036341 hasAuthorship W2151036341A5085293654 @default.
• W2151036341 hasAuthorship W2151036341A5087220330 @default.
• W2151036341 hasBestOaLocation W21510363411 @default.
• W2151036341 hasConcept C121608353 @default.
• W2151036341 hasConcept C126322002 @default.
• W2151036341 hasConcept C126894567 @default.
• W2151036341 hasConcept C141071460 @default.
• W2151036341 hasConcept C2776694085 @default.
• W2151036341 hasConcept C2779338040 @default.
• W2151036341 hasConcept C2780017030 @default.
• W2151036341 hasConcept C2780352672 @default.
• W2151036341 hasConcept C2781267111 @default.
• W2151036341 hasConcept C31174226 @default.
• W2151036341 hasConcept C71924100 @default.
• W2151036341 hasConceptScore W2151036341C121608353 @default.
• W2151036341 hasConceptScore W2151036341C126322002 @default.
• W2151036341 hasConceptScore W2151036341C126894567 @default.
• W2151036341 hasConceptScore W2151036341C141071460 @default.
• W2151036341 hasConceptScore W2151036341C2776694085 @default.
• W2151036341 hasConceptScore W2151036341C2779338040 @default.
• W2151036341 hasConceptScore W2151036341C2780017030 @default.
• W2151036341 hasConceptScore W2151036341C2780352672 @default.
• W2151036341 hasConceptScore W2151036341C2781267111 @default.
• W2151036341 hasConceptScore W2151036341C31174226 @default.
• W2151036341 hasConceptScore W2151036341C71924100 @default.
• W2151036341 hasIssue "1" @default.
• W2151036341 hasLocation W21510363411 @default.
• W2151036341 hasLocation W21510363412 @default.
• W2151036341 hasLocation W21510363413 @default.
• W2151036341 hasLocation W21510363414 @default.
• W2151036341 hasOpenAccess W2151036341 @default.
• W2151036341 hasPrimaryLocation W21510363411 @default.
• W2151036341 hasRelatedWork W1484554393 @default.
• W2151036341 hasRelatedWork W2414613480 @default.
• W2151036341 hasRelatedWork W2419654681 @default.
• W2151036341 hasRelatedWork W2463248341 @default.
• W2151036341 hasRelatedWork W2468728825 @default.

• next